If you would like to register, please email 2 preferred usernames to oceanfisher@gmail.com. You will be registered and sent instructions.
To start viewing messages,
select the forum that you want to visit from the selection below.

I'm glad Vertex picked it up and is moving forward now into a Phase 2b-3 for acute injury. A good trial for sure! It's for acute injury within 72 hours for those scheduled for decompression and stabilization of the spine. It will be running until June 2018. Estimated enrollment is 150 with some getting placebo. VX-210 is thought to act by promoting axon growth and helping neurons create new adaptive circuitry to overcome deficits caused by lost axonal connections after injury. VX-210 was licensed to Vertex to complete clinical development. I would hope they could add additional trial sites.

Apparently on chronics nothing ever works either. Or if something works, it magically disappears and we stop hearing about it and slowly forget about it as well.
Not implying anything, but something looks fishy and makes one wonder

i meant in the sense that acute trials are always discontinued or abandoned due to lack of efficacy... Chronic trials might take longer but I don't see "many" of them getting abandoned due to lack of efficacy exactly....

"That's not smog! It's SMUG!! " - randy marsh, southpark

"what???? , you don't 'all' wear a poop sac?.... DAMNIT BONNIE, YOU LIED TO ME ABOUT THE POOP SAC!!!! "

2010 SCINet Clinical Trial Support Squad Member
Please join me and donate a dollar a day at http://justadollarplease.org and copy and paste this message to the bottom of your signature